TORONTO–(BUSINESS WIRE)–ZYUS Life Sciences Corporation (the “Company”) is pleased to announce that it has entered into a debt exchange agreement to settle a certain outstanding promissory note in the aggregate amount of $1,000,000 CAD (the “Debt”) owing to a certain arm’s length creditor (the “Creditor”) with a due date of June 30, 2024 through the issuance of 1,000,000 common shares of the Company (the “Common Shares”) at a deemed price of $1.00 per Common Share (the “Transaction”). As part